| Bioactivity | EZH2-IN-15 (SHR2554) is a EZH2 inhibitor. EZH2-IN-15 has anti-tumor activity, and can be used for research of H3K27me3-dependent tumors[1]. |
| Name | EZH2-IN-15 |
| CAS | 2098545-98-1 |
| Formula | C32H44N4O4 |
| Molar Mass | 548.72 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Dale B, et al. Targeting Triple-Negative Breast Cancer by a Novel Proteolysis Targeting Chimera Degrader of Enhancer of Zeste Homolog 2. ACS Pharmacol Transl Sci. 2022 Jun 24;5(7):491-507. |
EZH2-IN-15
CAS: 2098545-98-1 F: C32H44N4O4 W: 548.72
EZH2-IN-15 (SHR2554) is a EZH2 inhibitor. EZH2-IN-15 has anti-tumor activity, and can be used for research of H3K27me3-d
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.